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Dissociated Oxygen Consumption and Carbon Dioxide Production in
the Post–Cardiac Arrest Rat: A Novel Metabolic Phenotype
Koichiro Shinozaki, MD, PhD; Lance B. Becker, MD; Kota Saeki, BEng; Junhwan Kim, PhD; Tai Yin, MD, PhD; Tong Da, MD, PhD;
Joshua W. Lampe, PhD
Background-—The concept that resuscitation from cardiac arrest (CA) results in a metabolic injury is broadly accepted, yet patients
never receive this diagnosis. We sought to ﬁnd evidence of metabolic injuries after CA by measuring O2 consumption and CO2
production (VCO2) in a rodent model. In addition, we tested the effect of inspired 100% O2 on the metabolism.
Methods and Results-—Rats were anesthetized and randomized into 3 groups: resuscitation from 10-minute asphyxia with inhaled
100% O2 (CA–fraction of inspired O2 [FIO2] 1.0), with 30% O2 (CA-FIO2 0.3), and sham with 30% O2 (sham-FIO2 0.3). Animals were
resuscitated with manual cardiopulmonary resuscitation. The volume of extracted O2 (VO2) and VCO2 were measured for a 2-hour
period after resuscitation. The respiratory quotient (RQ) was RQ=VCO2/VO2. VCO2 was elevated in CA-FIO2 1.0 and CA-FIO2 0.3
when compared with sham-FIO2 0.3 in minutes 5 to 40 after resuscitation (CA-FIO2 1.0: 16.72.2, P<0.01; CA-FIO2 0.3: 17.41.4,
P<0.01; versus sham-FIO2 0.3: 13.61.1 mL/kg per minute), and then returned to normal. VO2 in CA-FIO2 1.0 and CA-FIO2 0.3
increased gradually and was signiﬁcantly higher than sham-FIO2 0.3 2 hours after resuscitation (CA-FIO2 1.0: 28.76.7, P<0.01;
CA-FIO2 0.3: 24.42.3, P<0.01; versus sham-FIO2 0.3: 15.82.4 mL/kg per minute). The RQ of CA animals persistently
decreased (CA-FIO2 1.0: 0.540.12 versus CA-FIO2 0.3: 0.680.05 versus sham-FIO2 0.3: 0.930.11, P<0.01 overall).
Conclusions-—CA altered cellular metabolism resulting in increased VO2 with normal VCO2. Normal VCO2 suggests that the
postresuscitation Krebs cycle is operating at a presumably healthy rate. Increased VO2 in the face of normal VCO2 suggests a
signiﬁcant alteration in O2 utilization in postresuscitation. Several RQ values fell well outside the normally cited range of 0.7 to 1.0.
Higher FIO2 may increase VO2, leading to even lower RQ values. ( J Am Heart Assoc. 2018;7:e007721. DOI: 10.1161/JAHA.
117.007721.)
Key Words: CO2 production • cardiopulmonary resuscitation (CPR) • metabolism • O2 consumption • respiratory quotient
E xciting data from our laboratory have demonstrated thatour current understanding of aerobic respiration cannot
explain the O2 consumption (VO2) measured in rats resusci-
tated from prolonged cardiac arrest (CA), suggesting that we
have discovered a new postresuscitation metabolic phenotype.
CA is a time-dependent pathology,1 and the majority of
patients with CA are found more than 10 minutes after their
arrest occurred.2,3 Patients with long untreated arrest times
have the worst outcomes,2–4 in part because there is much to
learn about the injury sustained by patients resuscitated from
prolonged CA. The loss of blood ﬂow caused by CA is widely
acknowledged to cause a metabolic pathology, but we
struggle to measure the effect of this pathology at the
bedside. The cessation of blood ﬂow during CA stops delivery
of metabolic substrates and removal of metabolic waste
products, rapidly causing a variety of metabolic disorders
including loss of ATP, acidemia, hypercarbia, hyperlactemia,
loss of the adenosine pool, loss of ion gradients, and loss of
water control.5–9
Our inability to connect our understanding of the metabolic
injury caused by CA to the diagnosis and treatment of patients
is a major impediment to progress in the ﬁeld of resuscitation
science. There are promising clinical treatments, such as
therapeutic hypothermia, ischemic postconditioning, and
controlled reperfusion, which improve survival in preclinical
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studies and are hypothesized to address postresuscitation
metabolic disorders.10–13 However, there are a number of
randomized controlled clinical trials that show no beneﬁt,14–18
in part as a result of the lack of an ability to differentiate
patients with treatable metabolic injury, patients who might
live with proper treatment, from patients who do not have a
metabolic injury, patients who will live, or from patients with
untreatable metabolic injury, patients who will not live.4,19–21
Because of the central role of VO2 and CO2 production
(VCO2) in mitochondrial energy metabolism, and the evidence
that mitochondrial function is altered after resuscitation from
CA,22–24 we hypothesize that the metabolic injury sustained by
resuscitated animals will manifest as alterations in systemic
VO2 and VCO2. While ex vivo results suggest that VO2 will
decrease, we have purposefully left our hypothesis open
because the conditions used in ex vivo experimentation do not
reﬂect the postresuscitation cellular milieu. In order to test our
hypothesis, we developed a novel system for the measurement
of VO2 and VCO2 in intubated rats, and measured the VO2 and
VCO2 to enable the calculation of the respiratory quotient (RQ)
in a rat model of severe CA. VO2 and VCO2 were measured after
return of spontaneous circulation (ROSC) at an inspired O2
concentration of 30% and were compared with the results from
animals that received a sham surgery. In addition, we tested
whether the supplementation of inspired 100% O2 gas affected
the VO2, VCO2, or RQ in survivors of CA and compared results
from animals receiving 100% O2 with animals receiving 30% O2
or the sham surgery. We tested the effect of supplemental O2
on aerobic respiration after CA to determine whether the toxic
effects of supplemental O2 found in other injury models
25 are
replicated in this CA model.
Methods
The Institutional Animal Care and Use Committees of the
University of Pennsylvania, the Children’s Hospital of Philadel-
phia, and the Feinstein Institute for Medical Research
approved the study protocol. The data that support the
ﬁndings of this study are available from the corresponding
author upon reasonable request.
Animal Preparation
We performed all instrumentation according to the previously
described protocol.26 In brief, 34 adult male Sprague-Dawley
rats (450–550 g, Charles River Laboratories) were anes-
thetized with 4% isoﬂurane (Isosthesia, Butler-Schein AHS) and
intubated with a 14-gauge plastic catheter (Surﬂo, Terumo
Medical Corporation). We used male rats to avoid potential
differences among animal subjects that may be caused by
hormonal or genetic differences rather than differences from
the experimental intervention (ie, to minimize potential
sources of variability). Animals were mechanically ventilated
(Ventilator Model 683, Harvard Apparatus) at a minute
ventilation (MV) volume of 180 mL/min and a respiratory rate
of 45 breaths per minute. In this study, we used 1 ventilation
setting for all animals at all times and did not change the MV or
respiratory rate over the experiments. All measured end-tidal
CO2 values were within a range of 35 to 45 mm Hg during
preparation. Anesthesia was maintained with isoﬂurane 2%
and fraction of inspired O2 (FIO2) 0.3. The left femoral artery
was cannulated (sterile polyethylene-50 catheter inserted for
20 mm) for continuous arterial pressure monitoring (MLT844,
ADInstruments; Bridge Ampliﬁer ML221, ADInstruments). A
temperature probe (T-type thermocouple probes, ADInstru-
ments) was placed in the esophagus for continuous temper-
ature monitoring. The core temperature was maintained at
36.50.5°C during the surgical procedure. The left femoral
vein was cannulated with a polyethylene-50 catheter, which
was advanced into the inferior vena cava for drug infusion. This
catheter was ﬂushed with 150 U of heparin (Heparin, SAGENT
Pharmaceuticals). At the end of the preparation, a blood
sample (0.5 mL) was collected from the arterial catheter line
and a blood gas analysis (i-STAT, Heska) was performed.
Experimental Protocol: CA and Sham Animals
Animals were randomized into 3 groups at the end of surgery:
(1) successful resuscitation from 10-minute asphyxia arrest
treated with inhaled 100% O2: CA-FIO2 1.0 group (n=12);
Clinical Perspective
What Is New?
• Cardiac arrest altered cellular metabolism resulting in
increased O2 consumption with normal exhaled CO2 in a
rodent model.
• Increased O2 consumption in the face of normal exhaled
CO2 suggests a signiﬁcant alteration in O2 utilization in
postresuscitation.
• Our calculated respiratory quotient values, well outside the
normally cited range of 0.7 to 1.0 have been barely reported
in previous reports.
What Are the Clinical Implications?
• Higher concentration of inspired O2 may increase O2
consumption, leading to even lower respiratory quotient
values.
• Measuring O2 consumption and exhaled CO2 through
mechanical ventilation is noninvasive and our calculated
respiratory quotient values warrant larger animal and human
studies.
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(2) successful resuscitation from 10-minute asphyxia arrest
treated with inhaled 30% O2: CA-FIO2 0.3 group (n=10); and (3)
surgical sham control treated with inhaled 30% O2: sham-FIO2
0.3 group (n=12) (Figure 1). After instrumentation, neuromus-
cular blockade was achieved by slow intravenous administra-
tion of 2 mg/kg of vecuronium bromide (Hospira) for all groups
of animals. For animals in the CA groups, asphyxia was induced
by switching off the ventilator and CA occurred 3 to 4 minutes
after asphyxia started.WedeﬁnedCAas ameanarterial pressure
of <20 mm Hg; CA was completely untreated during this initial
10-minute interval. After the initial 10 minutes, mechanical
ventilation was restarted at an FIO2 of 1.0 and manual
cardiopulmonary resuscitation (CPR) was delivered to all CA
animals. Isoﬂurane inhalation was discontinued after the induc-
tion of asphyxia andwas not given toCA animals after successful
resuscitation. Chest compressions were performed with 2
ﬁngers over the sternum at a rate of 260 to 300 per minute.
Immediately after beginning CPR, a 20 lg/kg bolus of
epinephrine was given to animals through the venous catheter.
Following ROSC, deﬁned as systolic blood pressure
>60 mm Hg, CPR was discontinued. If ROSC did not occur by
5 minutes of CPR, resuscitation was terminated. Ten minutes
after CPR started, FIO2 was switched back to 0.3 in the CA-FIO2
0.3 group, while it was kept at 1.0 in the CA-FIO2 1.0 group. We
monitored animal physiology, VO2, and VCO2 for 120 minutes
after resuscitation. For animals in the sham-FIO2 0.3 group, the
samesurgical procedureswereperformed, including vecuronium
andepinephrine injections,without asphyxia orCPR. The animals
were consistently anesthetized with 2% inhaled isoﬂurane/30%
O2 during the entire series of measurements (Figure 1). All
surgical procedures including resuscitation were performed by 1
investigator and therefore blinding procedures were not applied.
Blood gas analysis was performed at 10, 20, 30, 45, 60, and
120 minutes after starting CPR. Mechanical ventilation was
discontinued 120 minutes after CPR and animal survival was
monitored up to 72 hours. Surviving animals were euthanized
72 hours after CPR. Postsurgical care including animal housing
and observation were provided by facility in a blinded manner.
Measurement Preparation
A photoluminescence-quenching sensor (FOXY AL300 Oxygen
Sensor Probe, Ocean Optics) and a ﬂuorometer (NEOFOX-GT,
Ocean Optics) were used to measure the gas concentration of
O2.O2wasmeasured inline in the exhalation or inhalation branch
of the ventilator circuit (Figure 2A and 2B). A micro-capnograph
(Micro-Capnograph CI240, Columbus Instruments) was used to
measure CO2. CO2 was measured using a continuous side-
streamsample taken fromtheendotracheal tubeof the intubated
animal (Figure 2A and 2B). The sampling rate was set at 10 mL/
min. The mechanical ventilation duty cycle was 50%, meaning
that 5 mL/min was taken from both the inspiration and the
expiration.Under a constant temperaturecondition,wemanually
calibrated theO2 and CO2 sensors before each experiment. Two-
point calibration was performed and medical air and medical O2
(General Welding Supply Corp.) were used for calibrating the O2
Figure 1. Study protocol. Animals were randomized into 3 groups at the end of surgery: (1) successful
resuscitation from 10-minute asphyxia arrest treated with inhaled 100% O2: cardiac arrest (CA)–fraction of
inspired O2 (FIO2) 1.0 group (n=12); (2) successful resuscitation from 10-minute asphyxia arrest treated with
inhaled 30% O2: CA-FIO2 0.3 group (n=10); and (3) surgical sham control treated with inhaled 30% O2: sham-
FIO2 0.3 group (n=12). CPR indicates cardiopulmonary resuscitation; ROSC, return of spontaneous circulation.
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sensor. We used 20.9% as a low reference and 100.0% as a high
reference. We used medical air (0% CO2) and industrial CO2
(10.4% CO2, General Welding Supply Corp.) for calibrating the
CO2 sensor. Gas humidity was measured inline with a hygrom-
eter (TFH620, ebro). The calibrationwas completedat a humidity
of 0%. A temperature probe (T-type thermocouple probes,
ADInstruments) and a pressure probe (MLT844, ADInstruments;
Bridge Ampliﬁer ML221, ADInstruments) were placed inline
(Figure 2A and 2B). Ambient temperature and pressure were
also monitored outside of the ventilator system (T-type thermo-
couple probes, ADInstruments; Traceable Workstation Digital
Barometer, Fisher Scientiﬁc).
VO2 and VCO2 Measures in Intubated Rats
The ﬂuorometer measures O2 concentration every 100 ms.
The ﬂuorometer performed a windowed average of these
measurements, and exported a value every second. The time
constant for the ﬂuorometer is about 300 ms. Given the
ventilation rate, this sensor is too slow to perform mainstream
O2 concentration measurements in the endotracheal tube. For
this reason, the O2 sensor was placed in the middle of a
ventilator tubing arm 100 cm from the endotracheal tube
(Figure 2). O2 concentrations were measured in the inspira-
tory arm (FIO2) or in the fraction of expired O2 arm (FEO2) by
swapping which ventilator circuit arm was connected to the in
and out port of the ventilator. Given enough equilibration time
after switching ventilator port connections, this setup pro-
vided relatively constant O2 concentrations for measurement.
The differences between the alveolar and tracheal O2
concentrations lead to a concentration gradient in the
expiratory arm of the ventilator circuit. However, the relatively
large volume of our ventilator circuit (15 mL) compared with
our tidal volume (4 mL) allowed sufﬁcient time for gas
Figure 2. Illustration of the mechanical ventilation circuit with 2 sensors for measurements of O2 and CO2 concentrations. A, Before and after
O2 consumption (VO2) measurements, fraction of inspired O2 (FIO2) is measured for at least 10 minutes. B, During measurements of VO2,
fraction of expired O2 (FEO2) is measured after the ventilator circuit has been switched. O2 extraction is calculated by a subtraction between
FIO2 and FEO2. C, Volume of exhaled gas (VE) was measured using a water bath and a 500 mL cylinder. For each measurement, expired gas was
collected for 2 minutes and minute ventilation of VE was calculated.
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diffusion, which signiﬁcantly decreased the O2 concentration
gradients in the expiratory arm of the circuit. After the
experiments, the exported O2 concentrations were averaged
every minute, and measurements made in the inspiratory arm
are reported as FIO2 and measurements made in the
expiratory arm are reported as FEO2. Figure 3 depicts a
typical experimental course of an animal in the CA-FIO2 1.0
group. Sensors were calibrated before each experiment.
Animal preparation was completed within 40 minutes after
successful intubation. Baseline FIO2 was measured during
surgical preparation. FEO2 was then measured by swapping
the in/out ports in the ventilator circuit (Figure 2A and 2B).
FIO2 was measured twice in each VO2 measurement for a
period of at least 10 minutes, before and after the 2-hour
period of FEO2 measurement. From asphyxia to starting CPR,
the rats were disconnected from the ventilator circuit and so a
test lung (small rubber balloon) was connected to the circuit.
FIO2 was measured with the test lung while the animal was in
asphyxia. After 10 minutes of asphyxia, the animal was
reconnected to the ventilator circuit, the ventilator circuit was
adjusted to measure FEO2, and CPR was initiated.
Because we measured CO2 concentration using a side-
stream breath-by-breath method, we used a slightly different
calculation for fractional concentration of CO2 in exhaled gas
(FECO2). To estimate FECO2, we quantitated % concentration
of CO2 from the capnograph waveform (Figure 4).
27 The small
increase in partial pressure of carbon dioxide (PCO2), noted as
phase Ι in Figure 4, marks the transition from inspiration to
expiration. This is followed by a signiﬁcant increase in PCO2,
labeled phase ΙΙ. The end of expiration at phase ΙΙΙ is deﬁned
as end-tidal PCO2. Capnograph data were extracted every
10 ms. We calculated the ﬁrst derivative of the capnograph to
detect the beginning of phase I and the end of phase III. The
interval starting from the beginning of phase I to the end of
phase III is considered the expiratory phase of the ventilation.
Using this method, we segmented the capnograph into
inspiratory and expiratory phases. Using only the expiratory
phases of the capnograph, we averaged 1 minute worth of
FECO2 measurements. The CO2 sensor is affected by changes
in the O2 concentration in the sampled gas. Therefore, we
corrected CO2 measurements empirically based on our sensor
calibration experiments, described below.
Figure 3. Experimental course of an animal. The ﬁgure depicts a typical experimental course of an animal
in the cardiac arrest (CA)–fraction of inspired O2 (FIO2) 1.0 group. We ﬁrstly performed sensor calibrations
for each experiment. Animal preparation was completed within 40 minutes after successful intubation.
Baseline FIO2 was measured during surgical preparation. Fraction of expired O2 (FEO2) was then measured
by swapping the in/out ports in the ventilator circuit. We measured FEO2 and monitored animal physiology,
O2 consumption (VO2), and CO2 production (VCO2) for 2 hours after resuscitation. FIO2 was measured
twice in each VO2 measurement, and before and after a 2-hour period of FEO2 measurement. CPR indicates
cardiopulmonary resuscitation.
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Tomeasure volume of exhaled gas (VE), we used an inverted,
water-sealed 500 mL cylinder that was ﬁlled with water.
Exhaled gas displaced the water in the cylinder during volume
measurements. Exhaled gas was collected for 2 minutes and
the MV volume was calculated. The resolution of the measure-
ment was 2.5 mL/min. VE measurements were performed
twice in each experiment before and after a 2-hour period of
metabolic measurement (Figure 2C). Ventilator airway pres-
sure was measured through our experiment so we could verify
that the pressure inside was kept positive by a positive end-
expiratory pressure of 2 cm (Figure 5). The positive pressure
inside the circuits ensures that the circuit is not contaminated
by ambient air. We regularly inspected the rat oropharynx
visually to eliminate the possibility of a major leak around the
endotracheal tube. Since the airway pressure was positive, gas
leak through the space between the endotracheal tube and the
vocal cords would create bubbles in the oropharynx. In addition,
we compared the VE measurements before and after the
metabolic measurement. The comparison of post-VE to pre-VE
was made for each experiment and the average ratio of post-
VE/pre-VE was 1.011 (95% conﬁdence interval, 0.994–1.028
[n=34]). This shows that the CA injury model had no observable
effect on our VE measurements.
Gas Concentration Measurements: Temperature
Control
Gas concentration measurements are temperature depen-
dent. The O2 and CO2 measurements used different temper-
ature control techniques. The micro-capnograph uses a
warming chamber to warm the sampled gas to 40°C. We
used a water bath and copper tubing to control the
temperature for the O2 sensor. The ﬂuorometer simultane-
ously measures ﬂuorescence and sample temperature in
order to correct for temperature effects. The water bath was
kept in a narrow temperature range of 19 to 21°C.
Measurement Validation
Four different 4% CO2 gas mixtures (4% CO2 contained in 10%,
45%, 80%, and 96% O2; MESA International Technologies, Inc)
Figure 4. Volumetric capnograph. Phase Ι is a starting point of
an expiration with a tiny elevation of the curve of partial pressure
of carbon dioxide (PCO2) followed by a steep slope of phase ΙΙ.
The end of expiration at phase ΙΙΙ is deﬁned as end-tidal PCO2.
Figure 5. Pressure curve inside the mechanical ventilator circuit. Ventilator airway pressure was
measured through our experiment so we could verify that the pressure inside was kept positive by a
positive end-expiratory pressure of 2 cm.
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were prepared. The accuracy of O2 and CO2 measurements
was tested using these mixtures. The error of our O2
measurements was 0.7% at a range from 20.9% to 100%.
Because we swapped the in/out ports and used 1 sensor for
measuring FIO2 and FEO2, the error (uncertainty) of FIO2 and
FEO2 were dependent. Since the propagation of uncertainty
for subtraction of FIO2FEO2 keeps the covariance,
rFIO2FEO2, in its calculation the error of O2 extraction rate,
FIO2FEO2, is calculated as 0.7% at a range from 20.9% to
100%.
We tested the effect of different O2 concentrations on our
CO2 sensor under humid conditions. Deionized pure water was
poured into Tygon tubing (Saint-Gobain) and it was warmed to
50°C by a hot water bath. The gas mixture was passed through
the tubing and the CO2 concentration was measured for each
mixture. In order to reduce CO2 measurement errors caused by
changes in O2 concentrations, we measured the effect of
different O2 concentrations on the CO2 sensor and created an
equation to correct the CO2 errors, as shown in Figure 6. The
CO2 concentration measurement decreased linearly as the O2
concentration increased. Humidity was 92.83.5% at a gas
temperature of 21.30.6°C. Based on this result, we derived
the following empirical equation:
CO2 ¼ mCO20:00077 O2 þ 1:0077 (1)
where, CO2 is the estimated concentration, mCO2 is the
measured value, O2 is the concentration of O2 (%).
Temperature and pressure are the major components that
affect the volume measure of a gas. Therefore, we tested
whether there were differences in temperature and/or
pressure between inhaled and exhaled gases before and after
swapping the in/out ports. Data were obtained 1 minute
before and after swapping the in/out ports of the ventilator
circuit. As can be seen in Table 1, the gas temperature was
19.690.46°C when FIO2 was measured and it increased by
0.01°C when FEO2 was measured. Even though exhaled gas
from animals is warmer than inhaled gas supplied from a
mechanical ventilator, it did not make a signiﬁcant impact on
our measurements because the water bath system controls
the temperature. The pressure inside the circuit was
5.620.42 mm Hg when FIO2 was measured and it
decreased by 0.19 mm Hg when FEO2 was measured.
The estimation of inspiration volume by the Haldane
transformation28 is limited to FIO2 <0.6.
29 We needed a
method that was applicable to FIO2 of 1.0. Therefore, we
performed an experiment to measure the effect of CO2
production and O2 consumption on the difference between VI
and VE, where VI and VE are MV volumes of the mechanical
ventilation in the inhaled and exhaled gases, respectively.
Before conducting the experiment, the ventilator and venti-
lator circuit were leak tested. The ﬁrst part of the experiment
was the determination of VI. The volume of gas exiting the
ventilator per minute was measured in the presence of a test
lung. Because the system was leak tested, and there was no
gas exchange in the test lung, the volume of gas exiting the
ventilator is equivalent to the volume of gas entering the test
lung, which is VI. This measurement was made in triplicate.
Then, an animal was anesthetized and intubated. The side-
stream capnography measurement was omitted and the port
sealed so that no ventilation volume was lost. The volume of
gas exiting the ventilator was then measured in triplicate. In
this setting, the measured volume is VE. Next, the animal was
euthanized by stopping mechanical ventilation under a
surgical plane of anesthesia and neuromuscular blockade.
This resulted in asphyxia and CA. VE was measured in
triplicate 15 and 45 minutes after euthanasia. Because the
animal was euthanized, the ventilations also resulted in no gas
exchange with the animal. The results of these experiments
are reported in Table 2. VI measured using the rubber-test
Figure 6. Effect of O2 concentration on the CO2 sensor. Four
different mixture gases (O2 10% and CO2 4%, O2 45% and CO2 4%,
O2 80% and CO2 4%, and O2 96% and CO2 4%) were used. The
experiment was performed under humid conditions at a relative
humidity of 92.83.5% at a gas temperature of 21.30.6°C.
Table 1. Gas Conditions for FIO2 and FEO2 Measurements of
Experimental Animals
FIO2 (n=5) FEO2 (n=5)
P
Value
Gas temperature
inside ventilator circuit, °C
19.690.46 19.700.46 <0.01
Gas pressure inside ventilator
circuit, mm Hg
5.620.42 5.430.44 <0.01
Ambient temperature, °C 21.690.26 21.670.15 0.886
Values are expressed as meanSD. The data were collected 1 minute before and after
swapping the in/out ports in the ventilator circuit. The results are shown as the average
and SD of data obtained from 5 animals. Paired-sample t test was used to compare the
values between fraction of inspired O2 (FIO2) and fraction of expired O2 (FEO2).
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lung was 177.5 mL/min. As can be seen in the Table 2, there
were no detectable differences between VE and VI in the
animal. The data support discarding the Haldane transforma-
tion in favor of the assumption that VI equals VE in animals,
particularly for high FIO2 values. However, it is possible that
the difference between VI and VE is smaller than the
resolution of our volume measurement. The resolution of
our volume measurement was 2.5 mL/min and so it was
1.4% of an MV of 180 mL/min. This number indicates that
VI can be 1.4% more or less than VE.
Calculations
VO2 and VCO2 are calculated by the following equations
29,30:
VO2 ¼ VI  FIO2VEFEO2 (2)
VCO2 ¼ VI  FICO2  VE  FECO2 (3)
In our calculation, FICO2 is assumed to be zero since the
inhaled gas did not contain CO2. It was not appropriate to use
the Haldane transformation28 to estimate VI from VE because
we used inhaled O2 concentrations of 100% in the CA-FIO2 1.0
group.29 Based on our validation study, we determined that it
was reasonable to assume that VI equals VE for this
experimental setup; this assumption results in the following
calculation of VO2:
VO2 ¼ VE  FIO2  FEO2ð Þ (4)
Room temperature and atmospheric pressure were measured
in each experiment so that VO2 and VCO2 could be calculated
at standard temperature and pressure. The RQ was calculated
by the following equation:
RQ ¼ VCO2=VO2 (5)
RQ ¼ FECO2
FIO2  FEO2 (6)
Different FIO2 settings affect errors in VO2 caused by the
assumption that VI equals VE. In order to evaluate errors in
VO2 of our study, we calculated %error from the following
equation:
%error ¼ Exact Approximate
Approximate
 100 (7)
Exact VO2 was calculated by equation (2), approximate VO2
was calculated by equation (4), and equation (6) is trans-
formed to:
%error¼ VIFIO2VEFEO2ð ÞVE FIO2FEO2ð Þ
VE FIO2FEO2ð Þ 100
(8)
%error ¼ VI
VE
 1
 
 FIO2
FIO2  FEO2
 
 100 (9)
The resolution of our VE measurement was 2.5 mL/min and it
was 1.4% of the MV volume (180 mL/min). We assumed that VI
equals VE but exact VI might be either more or less than VE
(1.4%). Therefore, the %error of our measurements is:
%error ¼ 1:4 FIO2
FIO2  FEO2
 
(10)
The %error becomes greater when higher inhaled O2 is used
and it becomes smaller when the animal’s O2 extraction rate,
FIO2FEO2, is high. In our injured animal model, the average of
O2 extraction rate was 7.5% when inhaled O2 was 30%, where it
was 9.3% when inhaled O2 was 100%. Therefore, the %error of
our VO2 measurements was estimated as 5.6% in the
CA-FIO2 0.3 group and 15.1% in the CA-FIO2 1.0 group.
Statistical Analysis
We reported continuous data as mean and SD. Group compar-
isonsweremadewith ANOVA, and Scheffemultiple comparison
procedure was used for post hoc analyses. The numbers of VO2,
VCO2, and RQ were compared within the 3 different test groups
(CA-FIO2 1.0 group, CA-FIO2 0.3 group, and sham-FIO2 0.3
group) at each time point. We used Fisher exact test for
comparison of categorical outcomes and log-rank test for
comparison of survival curves among groups. A 2-tailed P<0.05
was considered statistically signiﬁcant. All calculations were
performed with SPSS Statistics version 22 for Mac (IBM).
Results
CA Animal Models
No signiﬁcant differences in basal characteristics were found
between the groups (Table 3). Arterial O2 pressures for the 3
Table 2. Metabolic Effect on VE of an Animal
Test Lung
VI=VE, mL/min
Animal—Alive
VE, mL/min
Animal—Dead
15 min
VI=VE, mL/min
45 min
VI=VE, mL/min
177.50 177.50 176.71.4 177.50
One animal was used in this experiment. The volume measurements were repeated 3
times at each condition. Values are expressed as meanSD. VE indicates volume of
exhaled gas; VI, volume of inspired gas.
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groups are shown as a function of time in Figure 7. As
previously mentioned, we used 1 ventilation setting (respira-
tory rate: 45 breathes per minute; MV: 180 mL/min) for all
animals at all times and did not change the MV or respiratory
rate over the experiments. All measured end-tidal CO2 values
were within a range of 35 to 45 mm Hg during surgical
preparation. Mean PaO2 remained signiﬁcantly higher in the
CA-FIO2 1.0 group compared with the CA-FIO2 0.3 and the
sham-FIO2 0.3 groups. The %difference of PaO2 from baseline
decreased by 11% in the CA-FIO2 0.3 group at 60 and
120 minutes from CPR. There were no statistical differences
between the CA-FIO2 0.3 group and the sham-FIO2 0.3 group
(Figure 8). The %difference of arterial partial pressure of
carbon dioxide from baseline increased by 11% at 60 minutes
and by 19% at 120 minutes in the CA-FIO2 1.0 group, and
increased by 5% at 60 minutes and by 9% at 120 minutes in
the CA-FIO2 0.3 group. There were no statistical differences
between the 3 groups at either time point (Figure 8). Seventy-
two-hour survival curves for the 3 groups are shown in
Figure 9. Survival rates in the CA-FIO2 1.0 and the CA-FIO2
0.3 groups were not found to be different (P=0.164) using log-
rank test. Using Fisher exact test, the survival rates of CA-
FIO2 1.0 versus CA-FIO2 0.3 at each time point (24, 36, 48,
and 72 hours after CA) were 67% (8/12) versus 100% (10/
10, P=0.096), 42% (5/12) versus 80% (8/10, P=0.099), 33%
(4/12) versus 70% (7/10, P=0.198), and 25% (3/12) versus
40% (4/10, P=0.652), respectively. No animal died in the
sham-FIO2 0.3 group.
Alterations of VCO2, VO2, and RQ After CA
VCO2 was signiﬁcantly greater in both CA groups compared
with the sham group 25 minutes after ROSC (CA-FIO2 1.0:
16.72.2, P<0.01; CA-FIO2 0.3: 17.41.4, P<0.01; versus
sham-FIO2 0.3: 13.61.1 mL/kg per minute at standard
temperature and pressure, respectively). VCO2 in the CA
groups returned to normal 45 minutes after ROSC
Table 3. Basal Characteristics and Resuscitation Data in the
3 Groups
CA-FIO2 1.0
(n=12)
CA-FIO2 0.3
(n=10)
Sham
(n=12)
Weight, g 47932 46212 48036
CPR to ROSC time, s 10937 10030 
Tidal volume, mL/kg 7.40.6 7.70.2 7.20.8
FIO2 0.310.02 0.310.01 0.310.01
Body temperature, °C 36.60.3 36.70.4 36.90.4
Blood gas analysis
pH 7.460.03 7.440.02 7.440.02
PO2, mm Hg 14017 14616 14418
PCO2, mm Hg 402 404 425
Lactate, mmol/L 1.30.4 1.30.4 1.10.5
Blood samples were obtained from arterial line before asphyxia (baseline). Return of
spontaneous circulation (ROSC) time was deﬁned as systolic blood pressure
>60 mm Hg. Values are expressed as meanSD. CA indicates cardiac arrest; CPR,
cardiopulmonary resuscitation; FIO2, fraction of inspired O2; PCO2, partial pressure of
carbon dioxide; PO2, partial pressure of O2.
Figure 7. Arterial O2 pressure (arterial partial pressure of O2 [PaO2], mm Hg) among the 3 groups. Values
are expressed as meanSE. CA indicates cardiac arrest; CPR, cardiopulmonary resuscitation; FIO2, fraction
of inspired O2; ROSC, return of spontaneous circulation.
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(Figure 10A). As can be seen in Figure 10B, the VO2 value
was greater in the CA groups than in the sham group. Values
measured 115 to 120 minutes after ROSC were signiﬁcantly
different (CA-FIO2 1.0: 28.76.7, P<0.01; CA-FIO2 0.3:
24.42.3, P<0.01; versus sham-FIO2 0.3: 15.82.4 mL/kg
per minute at standard temperature and pressure). As a
result, the RQ was signiﬁcantly and persistently lower in the
CA groups than in the sham group over the 2-hour
measurement period (CA-FIO2 1.0: 0.540.12 versus CA-
FIO2 0.3: 0.680.05 versus sham-FIO2 0.3: 0.930.11 in
minutes 115 to 120 of ROSC, P<0.01 [Figure 10C]). The
proportion (numbers) of animals that had an RQ <0.7 at the
minimum was: 92% (11/12) in the CA-FIO2 1.0 group, 80% (8/
10) in the CA-FIO2 0.3 group, and 0% (0/12) in the sham-FIO2
0.3 group.
In our CA injury model, the VO2 value increased by 50%
when the FIO2 was 0.3. When the FIO2 value was 1.0, the VO2
increased by 80%.
Discussion
The experiments reported here demonstrate that animals
resuscitated from CA have reduced RQs, increased VO2 values,
and similar VCO2 values, relative to their pre-arrest values. The
amount of O2 consumed in the post-arrest period was
dependent on the inhaled O2 concentration. These results
conﬁrm our contention that resuscitation from CA causes
signiﬁcant metabolic injury to the animal. What was not
expected, and what has previously been considered impossible,
is that rats resuscitated from CA could exhibit RQs signiﬁcantly
lower than 0.7. Our expectations had been that resuscitated
animals would exhibit classical hypermetabolism or hypome-
tabolism, eg, their RQ would remain unchanged, but they would
exhibit either increased or decreased metabolic rate.
This study substantially improves our understanding of the
use of indirect calorimetry as a real-time metabolic monitor to
Figure 8. Arterial partial pressure of oxygen (PaO2) and arterial partial pressure of carbon dioxide (PaCO2) differences from baseline. The %
difference was compared from baseline in a value of PaO2 at 60 minutes after cardiopulmonary resuscitation (CPR) and 120 minutes after CPR.
The %difference was compared from baseline in a value of PaCO2 at 60 minutes after CPR and 120 minutes after CPR. There were no statistical
differences at any time points.
Figure 9. Kaplan–Meier survival curves among the 3 groups.
Log-rank test shows no signiﬁcant differences between the
cardiac arrest (CA)–fraction of inspired O2 (FIO2) 1.0 and CA-FIO2
0.3 groups (P=0.164).
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Figure 10. Alterations of CO2 production (VCO2), O2 consumption
(VO2), and RQ after cardiac arrest (CA). A, VCO2 over time in the CA
groups compared with the sham group; (B) VO2 over time in the CA groups
compared with the sham group; and (C) respiratory quotient (RQ) over
time in the CA groups compared with the sham group. CPR indicates
cardiopulmonary resuscitation; ROSC, return of spontaneous circulation.
Values are expressed as meanSE. The numbers of VO2, VCO2, and RQ
were compared within the 3 different test groups (CA–fraction of inspired
O2 [FIO2] 1.0 group, CA-FIO2 0.3 group, and sham-FIO2 0.3 group) at each
time point. Signiﬁcant differences between the groups with a P<0.05 is
indicated as *, P<0.01 ** (sham-FIO2 0.3 vs CA-FIO2 0.3), P<0.05 +, and
P<0.01 ++ (CA-FIO2 0.3 vs CA-FIO2 1.0).
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track injury severity after resuscitation. One of our most
important ﬁndings is that a resuscitated rat can sustain RQs
outside of the commonly cited range of 0.7 to 1.0. RQ values
<0.7 are often considered to be in error.30–33 Oshima et al32
reported 7 cases of CA in which energy expenditures were
found to be unexpectedly high in the post-ROSC period, but
excluded measurements when the RQ was lower than 0.7.
Black et al34 reported the results of a careful study of
mechanically ventilated patients in the intensive care unit with
VO2 measured using 3 distinct methods. In that article, nearly
25% of collected data were excluded from analysis because
the measured RQ was <0.6 or >1.2. An increase in the
metabolic rate, eg, hypermetabolism, has been reported in
patients with burns,35,36 sepsis,37 and other diseases.38,39
However, these reports did not include measurements of
VCO2 and therefore it is possible that a shift in O2
metabolism, such as the one described here, was interpreted
as hypermetabolism. In all, our results suggest that our
ﬁnding of an RQ <0.7 may be more prevalent than previously
suspected. Furthermore, our ﬁnding that changes in VO2 are
not always linked to changes in VCO2 clariﬁes that claims of
increased or decreased metabolic rate cannot be supported
without measuring both VO2 and VCO2.
There are some studies that report VO2 after CA using the
Fick method in rats,40,41 but the reported post-CA VO2 was
either comparable to or lower than the baseline measure-
ments or reference values in those studies. However, none of
these studies measured VCO2, thus the RQ values remain
unknown. Hensel and Kox42 reported that the number of VO2
measured by indirect calorimetry was higher than that by the
Fick method in patients with lung infection. It was inferred
that the injured lung itself might have measurable VO2.
We currently lack a biochemical explanation for the change
in O2 utilization manifested in these experiments. Under
normal aerobic respiration, nearly 95% of O2 is consumed as
the terminal electron accepter within the mitochondria’s
electron transport chain (Figure 11).43–45 The electrons that
are used to reduce O2 to water are supplied by the Krebs
cycle. The mitochondrial oxidation of glucose consumes 6 O2
molecules for each 6-carbon glucose molecule and generates
6 CO2 molecules to yield an RQ of 1, while the typical
b-oxidation of a fatty acid consumes 23 molecules of O2 for
each 16-carbon fatty acid, which will generate 16 CO2
molecules, yielding an RQ of 0.7. This stoichiometry deﬁnes
the “normal” range for RQ. In our experiments, the production
of CO2, and therefore the production of reducing equivalents
by the Krebs cycle, returned to baseline after 45 minutes, but
our VO2 increased to 150 or 200% of baseline, depending on
the inspired O2 fraction. This change represents a fundamen-
tal shift in the cellular utilization of O2.
There is an ongoing debate about the balance between the
potential beneﬁts and dangers of supplemental O2. It is
standard clinical practice to provide supplemental O2 when
the O2 saturation is low.
38 However, it has been shown that
supplemental O2 increases mortality in some critical illness
injury models.25 In our CA injury model, the VO2 increased by
50% when the FIO2 was 0.3. When the FIO2 was 1.0, the VO2
increased by 80%. Previous studies have shown that VO2 is
not dependent on the FIO2 in healthy animals and
humans.28,46 This is consistent with our biochemical under-
standing of mitochondrial respiration, which suggests that the
electron transport chain is nicotinamide adenine dinucleotide
limited.43,47 Therefore, we interpret our ﬁnding that VO2 is
dependent on the inspired O2 fraction in the CA animal model
as an indication that resuscitation may lead to metabolic
processes or states that are O2 limited. In our injury model,
the FIO2 1.0 group trended toward higher mortality than the
FIO2 0.3 group. While this was not statistically signiﬁcant with
our numbers, it appears consistent with previously published
results.25
The idea that resuscitation from CA results in “metabolic
injury” has become resuscitation science dogma. Alterations
in mitochondrial function have been detected in a variety of
CA models in a variety of animal species.22,24,48 Postischemic
conditioning has been shown to improve survival in swine
resuscitated from CA.49 The American Heart Association’s
guidelines highlight reperfusion injury as a problem resusci-
tated patients will face.19,50 While it remains unclear how our
ﬁndings relate to this spectrum of metabolic injuries, we have
demonstrated that signiﬁcant differences in the metabolisms
of resuscitated rats can be detected using indirect calorime-
try. Interestingly, the global metabolic rate in the resuscitated
rat did not appear to be increased or decreased. Instead, it
appears that additional O2 consuming processes are making a
signiﬁcant contribution to the total VO2 of the animal.
We believe this novel metabolic phenotype in rats resus-
citated from prolonged CA is in vivo evidence of postresus-
citation metabolic injury, and might be used to estimate
severity of postresuscitation injury. Measuring VO2, VCO2,
and RQ is noninvasive and can be translated into larger animal
and human studies. However, currently available medical
devices are associated with measurement limitations that
undermine their accuracy.44,51,52 However, a reliable device
could be easily designed and constructed using existing
technology, and we anticipate validating our ﬁnding in human
survivors of CA.
There are no commercially available methods to measure
VO2 and VCO2 in mechanically ventilated rodents. However,
we have conﬁdence in our O2 and CO2 measurements
because our baseline VO2 and VCO2 values are consistent
with reports from other rodent laboratories. For example,
Barrow36 reported VO2 in the range of 13 to 18 mL/kg per
minute (800–1100 mL/kg per hour) in rats with sham
surgery, which matches our measured VO2 range of 16 to
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18 mL/kg per hour in our sham group animals. Yamaoka
et al53 used a commercially available metabolic chamber for
rats and reported that VCO2 was 14 to 20 mL/min per kg
(10–14 mL/min per kg0.75) at sleep and 25 to 31 mL/min
per kg (18–22 mL/min per kg0.75) at normal activity. Musch
et al54 reported that VCO2 was 20 mL/min per kg at rest and
67 to 72 mL/min per kg at maximal exercise. VCO2 in our
sham group animals was 14 to 16 mL/min per kg. This
number is close to that of sleeping animals but less than
animals at normal activity or rest. VCO2 of the baseline and
the sham surgery animals were measured under anesthesia
and it is reasonable that the number we reported was close or
less than those of nonanesthetized animals. We interpret this
congruence with reported values as evidence that our system
provides reasonable measurements.
There are at least 3 biochemical pathways that could
explain the imbalance between VO2 and VCO2. The ﬁrst is that
cytochrome c oxidase is consuming the additional O2 with
extra reducing equivalents being provided by processes that
do not generate CO2, eg, processes other than the Krebs
cycle such as glycerol-phosphate shuttle and/or the malate-
aspartate shuttle pathways providing the electron transport
chain with FADH2 and nicotinamide adenine dinucleotide,
respectively.55,56 The second is that the amount of O2 being
consumed by oxidases and oxygenases other than cyto-
chrome c oxidase has increased. Nonmitochondrial VO2 has
been described (Figure 11)57,58 and these reactions do not
involve nicotinamide adenine dinucleotide or FADH2 in
mitochondria, and therefore are not coupled to CO2 created
by the Krebs cycle. Enzymes such as nicotinamide adenine
dinucleotide phosphate oxidases, cytochrome p450 oxidases,
monoamine oxidases, and xanthine oxidases59 primarily
oxidize water without a concomitant production of CO2. The
third is the prolonged production of reactive O2 species within
the electron transport chain enzymes. The creation of
superoxide requires a single electron to reduce molecular
O2, where normal electron transfer requires 4 electrons to
reduce molecular O2.
60 This would shift the balance of VO2
and VCO2 in the direction we have observed. All these
provisions could create a situation where O2 is the rate-
limiting substrate for the electron transport chain, which
could explain our observation that post-arrest VO2 is O2
concentration dependent.
Study Limitations
This study is subject to several limitations. The ﬁrst is that we
studied post-arrest metabolism in rats. The novel ﬁndings
reported in this article may not be found in humans.61 We are
currently conducting human studies to seek this newly found
phenotype in survivors of CA. Second, the control group, the
sham-FIO2 0.3 group, has 2 differences relative to the CA
Figure 11. Pathways of cellular energy metabolism and O2 consumption (VO2). ATP indicates adenosine
triphosphate; Cyt c, cytochrome c oxidase; ETC, electron transport chain; KC, Krebs cycle; NADPH,
nicotinamide adenine dinucleotide phosphate.
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groups: it is missing the injury and it includes isoﬂurane,
which is absent in the other groups after successful
resuscitation. It is plausible that isoﬂurane alters the systemic
metabolism in rodents. However, our VO2, VCO2, and RQ
values in the sham-FIO2 0.3 group are within a range reported
for other rat models in the absence of isoﬂurane.36,62 This
suggests that the CA injury is solely responsible for the
observed changes in RQ values. Finally, our volume measure-
ments may underestimate the true tidal volume. It is possible
that there was a small amount of leakage around the uncuffed
endotracheal tube used in these studies. In addition, we used
a side-stream capnograph and its sampling rate was set at
10 mL/min. However, our baseline VO2 and VCO2 values fall
into the previously reported range, and we see no evidence
that the CA injury had any additional effect on tidal volumes
or airway pressures.
Conclusions
We provide real-time, in vivo evidence of a novel postresus-
citation metabolic phenotype in resuscitated rats measured
by indirect calorimetry. The phenotype is characterized by a
50% to 100% increase in VO2 without a concomitant increase
in VCO2. As such, the metabolic phenotype is not a change in
metabolic rate but a fundamental shift in cellular O2
utilization. There are several possible biochemical explana-
tions for this phenomenon, but they remain untested. Our
ﬁndings may be relevant to basic scientists who study O2
metabolism and cellular biochemistry, as well as to clinicians
who seek better monitoring technologies and therapies for
the treatment of CA.
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